This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Skyhawk Therapeutics, Inc., Vertex Pharmaceuticals, Inc.. Active years: 2014-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2024
Title: Innovations by Inventor Jun Feng
Introduction
Jun Feng is an accomplished inventor based in Acton, MA, with a focus on developing innovative solutions in the field of molecular biology. He holds two patents that showcase his expertise in modulating splicing and inhibiting influenza virus replication. His work has significant implications for treating various diseases and conditions.
Latest Patents
Feng's latest patents include "Methods and compositions for modulating splicing," which describes small molecule splicing modulator compounds that can modulate the splicing of mRNA, such as pre-mRNA, encoded by genes. This patent outlines pharmaceutical compositions comprising these compounds and methods for their use in treating diseases. Another notable patent is "Inhibitors of influenza viruses replication," which details methods for inhibiting the replication of influenza viruses in biological samples or patients. This patent emphasizes the administration of effective amounts of specific compounds to treat influenza effectively.
Career Highlights
Throughout his career, Jun Feng has worked with prominent companies in the biotechnology sector, including Vertex Pharmaceuticals, Inc. and Skyhawk Therapeutics, Inc. His contributions to these organizations have been instrumental in advancing research and development in therapeutic solutions.
Collaborations
Feng has collaborated with notable professionals in his field, including Paul S. Charifson and Michael P. Clark. These collaborations have further enriched his research and innovation efforts.
Conclusion
Jun Feng's contributions to the field of molecular biology through his patents and collaborations highlight his role as a significant innovator. His work continues to pave the way for advancements in medical treatments and therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
